Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3
Fujimaki, M.; Nagasawa, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
1974
ISSN/ISBN: 0047-1852 PMID: 4211348 Document Number: 80103
Document emailed within 1 workday
Related Documents
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Stürner, K.H.; Holzhüter, H.; Ochs, H.G.; Angelkort, B.; Muchietti, F.; Wenzel, E. 1973: Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1328-1330
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Kamikubo, Y.; Hamuro, T.; Matsuda, J.; Shinya, N.; Miyamoto, S.; Funatsu, A.; Kato, H. 1996: Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: concerted effect with antithrombin Thrombosis and Haemostasis 76(4): 621-626
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Aiach, M.; Andreux, J.P.; Fiessinger, J.N.; Beuvin, J.; Leclerc, M. 1976: Antithrombin IIi during coagulation in vitro Annales Pharmaceutiques Francaises 34(1-2): 43-50
Kase, F.; Pospísil, J. 1983: The physiological inhibitors of blood coagulation. 1. Antithrombin IIi (AT III) Folia Haematologica 110(3): 337-349
Król-Grela, H.; Piastucka, B.; Skotnicki, A.B. 1988: The role of antithrombin III in disorders of blood coagulation Przeglad Lekarski 45(6): 516-520
Bärtsch, P.; Haeberli, A.; Straub, P.W. 1990: Blood coagulation after long distance running: antithrombin III prevents fibrin formation Thrombosis and Haemostasis 63(3): 430-434
Saxena, V.; Mishra, D.K.; Subramanya, H.; Satyanarayana, S.; Sharma, A. 2004: Antithrombin IIi assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases Indian Journal of Pathology and Microbiology 47(2): 210-212
Dolesobel, W. 1972: Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin i effect of fibrin Wiener Medizinische Wochenschrift 122(41): 585-590
Ogawa, K.; Baba, S.; Funazaki, K.; Nakanishi, K.; Hirohashi, K.; Suzuki, E.; Tamura, M. 1984: The values of plasminogen, antithrombin III, factor XIIi and fibrinogen according to age and sex Rinsho Byori. Japanese Journal of Clinical Pathology 32(6): 679-682
van Boven, H.H.; Reitsma, P.H.; Rosendaal, F.R.; Bayston, T.A.; Chowdhury, V.; Bauer, K.A.; Scharrer, I.; Conard, J.; Lane, D.A. 1996: Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency Thrombosis and Haemostasis 75(3): 417-421
Bajwa, S.S. 1981: A new type of antithrombotic agent: action of antithrombin IIi - factor Xa complex Proceedings of the Western Pharmacology Society 24: 275-279
Leroy-Matheron, C.; Gouault-Heilmann, M. 1994: Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements Thrombosis Research 74(4): 399-407
Gordon, E.M.; Williams, S.R.; Frenchek, B.; Mazur, C.A.; Speroff, L. 1988: Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin IIi and factor XIi Journal of Laboratory and Clinical Medicine 111(1): 52-56
Bouissou, F.; Barthe, P.; Boneu, B. 1980: Acquired deficiency of factor XIi and antithrombin IIi (AT III) in nephroses of children. Preliminary results La Nouvelle Presse Medicale 9(25): 1778
Lane, D.A.; Ryan, K. 1990: The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins Journal of Laboratory and Clinical Medicine 116(2): 269-270